Cargando…
Long-term outcome after surgery in a patient with intestinal Behçet’s disease complicated by myelodysplastic syndrome and trisomy 8
Behçet’s disease (BD) is a multisystem inflammatory disease of unknown origin. Rarely, BD occurs together with myelodysplastic syndrome (MDS). Interestingly, it is speculated that these are not simple coexistence but that the etiology of intestinal BD is at least partly derived from MDS itself. Furt...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association for the Study of Intestinal Diseases
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609388/ https://www.ncbi.nlm.nih.gov/pubmed/32388943 http://dx.doi.org/10.5217/ir.2019.09141 |
_version_ | 1783605022623268864 |
---|---|
author | Mori, Yuki Iwamoto, Fumihiko Ishida, Yasuaki Kuno, Toru Kobayashi, Shoji Yoshida, Takashi Yamaguchi, Tatsuya Sato, Tadashi Sudo, Makoto Ichikawa, Daisuke Enomoto, Nobuyuki |
author_facet | Mori, Yuki Iwamoto, Fumihiko Ishida, Yasuaki Kuno, Toru Kobayashi, Shoji Yoshida, Takashi Yamaguchi, Tatsuya Sato, Tadashi Sudo, Makoto Ichikawa, Daisuke Enomoto, Nobuyuki |
author_sort | Mori, Yuki |
collection | PubMed |
description | Behçet’s disease (BD) is a multisystem inflammatory disease of unknown origin. Rarely, BD occurs together with myelodysplastic syndrome (MDS). Interestingly, it is speculated that these are not simple coexistence but that the etiology of intestinal BD is at least partly derived from MDS itself. Furthermore, there is a relationship between MDS in patients with intestinal BD and trisomy 8. Immunosuppressive agents alone are insufficient to control MDS-associated BD, and many of these patients die of infection or hemorrhage. Surgery is considered for intestinal BD patients who are unresponsive to medical treatment or those with bowel complications such as perforation or persistent bleeding. We report a case of intestinal BD associated with MDS and trisomy 8. The patient was unresponsive to oral steroids and immunosuppressive treatment; the patient improved by surgical repair of a bowel perforation. Five years after the surgery, the patient is free of recurrence and not on medication. Our experience suggests that surgery may provide an effective therapeutic option for the treatment of MDS-related BD. |
format | Online Article Text |
id | pubmed-7609388 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Korean Association for the Study of Intestinal Diseases |
record_format | MEDLINE/PubMed |
spelling | pubmed-76093882020-11-10 Long-term outcome after surgery in a patient with intestinal Behçet’s disease complicated by myelodysplastic syndrome and trisomy 8 Mori, Yuki Iwamoto, Fumihiko Ishida, Yasuaki Kuno, Toru Kobayashi, Shoji Yoshida, Takashi Yamaguchi, Tatsuya Sato, Tadashi Sudo, Makoto Ichikawa, Daisuke Enomoto, Nobuyuki Intest Res Case Report Behçet’s disease (BD) is a multisystem inflammatory disease of unknown origin. Rarely, BD occurs together with myelodysplastic syndrome (MDS). Interestingly, it is speculated that these are not simple coexistence but that the etiology of intestinal BD is at least partly derived from MDS itself. Furthermore, there is a relationship between MDS in patients with intestinal BD and trisomy 8. Immunosuppressive agents alone are insufficient to control MDS-associated BD, and many of these patients die of infection or hemorrhage. Surgery is considered for intestinal BD patients who are unresponsive to medical treatment or those with bowel complications such as perforation or persistent bleeding. We report a case of intestinal BD associated with MDS and trisomy 8. The patient was unresponsive to oral steroids and immunosuppressive treatment; the patient improved by surgical repair of a bowel perforation. Five years after the surgery, the patient is free of recurrence and not on medication. Our experience suggests that surgery may provide an effective therapeutic option for the treatment of MDS-related BD. Korean Association for the Study of Intestinal Diseases 2020-10 2020-05-12 /pmc/articles/PMC7609388/ /pubmed/32388943 http://dx.doi.org/10.5217/ir.2019.09141 Text en © Copyright 2020. Korean Association for the Study of Intestinal Diseases. All rights reserved. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Mori, Yuki Iwamoto, Fumihiko Ishida, Yasuaki Kuno, Toru Kobayashi, Shoji Yoshida, Takashi Yamaguchi, Tatsuya Sato, Tadashi Sudo, Makoto Ichikawa, Daisuke Enomoto, Nobuyuki Long-term outcome after surgery in a patient with intestinal Behçet’s disease complicated by myelodysplastic syndrome and trisomy 8 |
title | Long-term outcome after surgery in a patient with intestinal Behçet’s disease complicated by myelodysplastic syndrome and trisomy 8 |
title_full | Long-term outcome after surgery in a patient with intestinal Behçet’s disease complicated by myelodysplastic syndrome and trisomy 8 |
title_fullStr | Long-term outcome after surgery in a patient with intestinal Behçet’s disease complicated by myelodysplastic syndrome and trisomy 8 |
title_full_unstemmed | Long-term outcome after surgery in a patient with intestinal Behçet’s disease complicated by myelodysplastic syndrome and trisomy 8 |
title_short | Long-term outcome after surgery in a patient with intestinal Behçet’s disease complicated by myelodysplastic syndrome and trisomy 8 |
title_sort | long-term outcome after surgery in a patient with intestinal behçet’s disease complicated by myelodysplastic syndrome and trisomy 8 |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609388/ https://www.ncbi.nlm.nih.gov/pubmed/32388943 http://dx.doi.org/10.5217/ir.2019.09141 |
work_keys_str_mv | AT moriyuki longtermoutcomeaftersurgeryinapatientwithintestinalbehcetsdiseasecomplicatedbymyelodysplasticsyndromeandtrisomy8 AT iwamotofumihiko longtermoutcomeaftersurgeryinapatientwithintestinalbehcetsdiseasecomplicatedbymyelodysplasticsyndromeandtrisomy8 AT ishidayasuaki longtermoutcomeaftersurgeryinapatientwithintestinalbehcetsdiseasecomplicatedbymyelodysplasticsyndromeandtrisomy8 AT kunotoru longtermoutcomeaftersurgeryinapatientwithintestinalbehcetsdiseasecomplicatedbymyelodysplasticsyndromeandtrisomy8 AT kobayashishoji longtermoutcomeaftersurgeryinapatientwithintestinalbehcetsdiseasecomplicatedbymyelodysplasticsyndromeandtrisomy8 AT yoshidatakashi longtermoutcomeaftersurgeryinapatientwithintestinalbehcetsdiseasecomplicatedbymyelodysplasticsyndromeandtrisomy8 AT yamaguchitatsuya longtermoutcomeaftersurgeryinapatientwithintestinalbehcetsdiseasecomplicatedbymyelodysplasticsyndromeandtrisomy8 AT satotadashi longtermoutcomeaftersurgeryinapatientwithintestinalbehcetsdiseasecomplicatedbymyelodysplasticsyndromeandtrisomy8 AT sudomakoto longtermoutcomeaftersurgeryinapatientwithintestinalbehcetsdiseasecomplicatedbymyelodysplasticsyndromeandtrisomy8 AT ichikawadaisuke longtermoutcomeaftersurgeryinapatientwithintestinalbehcetsdiseasecomplicatedbymyelodysplasticsyndromeandtrisomy8 AT enomotonobuyuki longtermoutcomeaftersurgeryinapatientwithintestinalbehcetsdiseasecomplicatedbymyelodysplasticsyndromeandtrisomy8 |